Since December, YIDU TECH (02158) has bought back its own stock 11 times, showcasing its development confidence recognized by multiple international parties.

On December 19, YIDU TECH (02158) announced that it had repurchased 93,500 shares at a price of HK$5.23 per share, with a total repurchase amount of approximately HK$490,000. Since December, the company has repurchased a total of 11 times, repurchasing approximately 3.44 million shares with a total amount exceeding HK$17.4 million. This move aims to strengthen market confidence and demonstrate YIDU TECH's strong outlook for its own development. In terms of news, YIDU TECH has recently been widely recognized in the industry and international cooperation field. At the annual conference of the Digital Medicine Research Institute of the City University of Hong Kong, the company's founder and chairman, Ms. Gong Rujing, was appointed as a member of the Institute's Advisory Committee, showcasing the industry's recognition and trust in YIDU TECH and its strategic leader Ms. Gong Rujing's innovative practices in the field of AI healthcare. Furthermore, YIDU TECH has made a significant breakthrough on the international stage of multilateral cooperation: the Health Sustainable Development Working Committee of the Shanghai Cooperation Organization Multifunctional Economic and Trade Platform (SCO Home) was recently established, and YIDU TECH was successfully selected as a member organization; the company's co-founder and CEO, Xu Jiming, was elected as the first session of the committee, marking the company's professional capabilities and industry status in the international digital health cooperation field receiving authoritative endorsement. In recent years, YIDU TECH's international strategic layout has been steadily advancing, with its business and customer network expanding to six regions worldwide. Through deep collaboration with local government departments, medical institutions, and research institutes, it has built a mature localized cooperation ecosystem. Its intelligent solutions have been widely implemented in key areas such as infectious disease monitoring and warning, national population health management, AI-assisted diagnosis and treatment, and personalized health management, continuously empowering global health development with the power of technology.